Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Hunan Intellectual and Developmental Disabilities Research Center, Changsha, Hunan 410008, China.
Chin Med J (Engl). 2019 Jul 5;132(13):1533-1540. doi: 10.1097/CM9.0000000000000295.
Advanced technology has become a valuable tool in etiological studies of intellectual disability/global developmental delay (ID/GDD). The present study investigated the role of genetic analysis to confirm the etiology in ID/GDD patients where the cause of the disease was uncertain in central China.
We evaluated 1051 ID/GDD children aged 6 months to 18 years from March 2009 to April 2017. Data concerning basic clinical manifestations were collected, and the method of etiology confirmation was recorded. Genome-wide copy number variations (CNVs) detection and high-throughput sequencing of exons in the targeted regions was performed to identify genetically-based etiologies. We compared the incidence of different methods used to confirm ID/GDD etiology among groups with differing degrees of ID/GDD using the Chi-square or Fisher exact probability test.
We recruited 1051 children with mild (367, 34.9%), moderate (301, 28.6%), severe (310, 29.5%), and profoundly severe (73, 6.9%) ID/GDD. The main causes of ID/GDD in the children assessed were perinatal factors, such as acquired brain injury, as well as single gene imbalance and chromosomal gene mutation. We identified karyotype and/or CNVs variation in 46/96 (47.9%) of cases in severe ID/GDD patients, which was significantly higher than those with mild and moderate ID/GDD of 34/96 (35.4%) and 15/96 (15.6%), respectively. A total of 331/536 (61.8%) patients with clear etiology have undergone genetic analysis while 262/515 (50.9%) patients with unclear etiology have undergone genetic analysis (χ = 12.645, P < 0.001). Gene structure variation via karyotype analysis and CNV detection increased the proportion of children with confirmed etiology from 51.0% to 56.3%, and second-generation high-throughput sequencing dramatically increased this to 78.9%. Ten novel mutations were detected, recessive mutations in X-linked genes (ATPase copper transporting alpha and bromodomain and WD repeat domain containing 3) and dominant de novo heterozygous mutations in X-linked genes (cyclin-dependent kinase like 5, protocadherin 19, IQ motif and Sec7 domain 2, and methyl-CpG binding protein 2) were reported in the study.
The present study indicates that genetic analysis is an effective method to increase the proportion of confirmed etiology in ID/GDD children and is highly recommended, especially in ID/GDD children with uncertain etiology.
先进技术已成为智力障碍/全面发育迟缓(ID/GDD)病因学研究的有价值工具。本研究旨在探讨基因分析在确认中国中部病因不明的 ID/GDD 患者病因中的作用。
我们评估了 2009 年 3 月至 2017 年 4 月期间 1051 名 6 个月至 18 岁的 ID/GDD 儿童。收集了基本临床表现的数据,并记录了病因确认方法。通过全基因组拷贝数变异(CNV)检测和靶向区域外显子的高通量测序,确定了遗传病因。我们比较了不同 ID/GDD 严重程度组之间使用不同方法确认 ID/GDD 病因的发生率,使用卡方或 Fisher 精确概率检验。
我们招募了 1051 名轻度(367 例,34.9%)、中度(301 例,28.6%)、重度(310 例,29.5%)和极重度(73 例,6.9%)ID/GDD 儿童。评估儿童 ID/GDD 的主要病因是围产期因素,如获得性脑损伤,以及单基因失衡和染色体基因突变。我们在 46/96(47.9%)严重 ID/GDD 患者中发现了核型和/或 CNV 变化,明显高于轻度和中度 ID/GDD 的 34/96(35.4%)和 15/96(15.6%)。331/536(61.8%)有明确病因的患者接受了基因分析,而 262/515(50.9%)病因不明的患者接受了基因分析(χ²=12.645,P<0.001)。通过核型分析和 CNV 检测发现基因结构变异,使确认病因的患儿比例从 51.0%增加到 56.3%,第二代高通量测序使这一比例显著增加到 78.9%。本研究还发现了 10 种新突变,X 连锁基因(ATPase 铜转运α和溴结构域和 WD 重复域蛋白 3)的隐性突变和 X 连锁基因(细胞周期蛋白依赖性激酶样 5、原钙黏蛋白 19、IQ 基序和 Sec7 域 2、甲基-CpG 结合蛋白 2)的显性从头杂合突变。
本研究表明,基因分析是提高 ID/GDD 患儿确诊病因比例的有效方法,强烈推荐使用,尤其是病因不明的 ID/GDD 患儿。